Kalaris Therapeutics Inc (KLRS) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Cambridge, MA, 美国. 现任CEO为 Andrew Oxtoby.
KLRS 拥有 IPO日期为 2020-07-30, 14 名全职员工, 在 NASDAQ Global Market, 市值为 $109.78M.
Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.
